IL105229A0 - The use of 7-oxo-7h-pyrido(1,2,3-de)(1,4)benzoxazine-6-carboxylic acids and esters as medicaments - Google Patents
The use of 7-oxo-7h-pyrido(1,2,3-de)(1,4)benzoxazine-6-carboxylic acids and esters as medicamentsInfo
- Publication number
- IL105229A0 IL105229A0 IL105229A IL10522993A IL105229A0 IL 105229 A0 IL105229 A0 IL 105229A0 IL 105229 A IL105229 A IL 105229A IL 10522993 A IL10522993 A IL 10522993A IL 105229 A0 IL105229 A0 IL 105229A0
- Authority
- IL
- Israel
- Prior art keywords
- benzoxazine
- pyrido
- medicaments
- oxo
- esters
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/06—Peri-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/538—1,4-Oxazines, e.g. morpholine ortho- or peri-condensed with carbocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Virology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Quinoline Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE4210939A DE4210939A1 (de) | 1992-04-02 | 1992-04-02 | Verwendung von 7-Oxo-7H-pyrido[1,2,3-de][1,4]benzoxacin-6-carbonsäuren und -estern als Arzneimittel |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL105229A0 true IL105229A0 (en) | 1993-07-08 |
Family
ID=6455791
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL105229A IL105229A0 (en) | 1992-04-02 | 1993-03-31 | The use of 7-oxo-7h-pyrido(1,2,3-de)(1,4)benzoxazine-6-carboxylic acids and esters as medicaments |
Country Status (13)
| Country | Link |
|---|---|
| EP (1) | EP0563733A1 (es) |
| JP (1) | JPH0616560A (es) |
| KR (1) | KR930021208A (es) |
| CN (1) | CN1077886A (es) |
| AU (1) | AU3569193A (es) |
| CA (1) | CA2093106A1 (es) |
| DE (1) | DE4210939A1 (es) |
| HU (1) | HU9300925D0 (es) |
| IL (1) | IL105229A0 (es) |
| MX (1) | MX9301667A (es) |
| NO (1) | NO931009L (es) |
| PL (1) | PL298321A1 (es) |
| ZA (1) | ZA932349B (es) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR100333764B1 (ko) * | 1999-09-03 | 2002-04-25 | 신영균 | 아크스폿 용접용 보조장치 |
| AR048650A1 (es) * | 2004-05-04 | 2006-05-10 | Tibotec Pharm Ltd | Derivados de (1,10b-dihidro-2-(aminocarbonil-fenil)-5h-pirazolo[1,5 c][1,3]benzoxazin-5-il)fenil metanona como inhibidores de la replicacion viral del vih |
| TW200710091A (en) * | 2005-04-11 | 2007-03-16 | Tibotec Pharm Ltd | (1,10B-dihydro-2-(aminoalkyl-phenyl)-5H-pyrazolo [1,5-c][1,3]benzoxazin-5-yl)phenyl methanone derivatives as HIV viral replication inhibitors |
| KR20060093321A (ko) * | 2006-08-05 | 2006-08-24 | 박장용 | 와이어 송급 장치에서 크레이터를 설정할 수 있는 용접기시스템 |
| CN102260277B (zh) * | 2010-05-24 | 2013-07-24 | 中国科学院上海药物研究所 | 新型苯并噁嗪噁唑烷酮类化合物及其制备方法和用途 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3623757A1 (de) * | 1986-07-15 | 1988-01-21 | Bayer Ag | Neue 1,8-verbrueckte 4-chinoloncarbonsaeuren und diese enthaltende arzneimittel |
-
1992
- 1992-04-02 DE DE4210939A patent/DE4210939A1/de not_active Withdrawn
-
1993
- 1993-03-19 NO NO93931009A patent/NO931009L/no unknown
- 1993-03-22 EP EP93104661A patent/EP0563733A1/de not_active Withdrawn
- 1993-03-23 KR KR1019930004470A patent/KR930021208A/ko not_active Application Discontinuation
- 1993-03-25 MX MX9301667A patent/MX9301667A/es unknown
- 1993-03-30 HU HU9300925A patent/HU9300925D0/hu unknown
- 1993-03-30 CA CA002093106A patent/CA2093106A1/en not_active Abandoned
- 1993-03-31 IL IL105229A patent/IL105229A0/xx unknown
- 1993-03-31 PL PL29832193A patent/PL298321A1/xx unknown
- 1993-04-01 JP JP5096508A patent/JPH0616560A/ja active Pending
- 1993-04-01 ZA ZA932349A patent/ZA932349B/xx unknown
- 1993-04-02 AU AU35691/93A patent/AU3569193A/en not_active Abandoned
- 1993-04-02 CN CN93103503A patent/CN1077886A/zh active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| EP0563733A1 (de) | 1993-10-06 |
| NO931009L (no) | 1993-10-04 |
| HU9300925D0 (en) | 1993-06-28 |
| JPH0616560A (ja) | 1994-01-25 |
| ZA932349B (en) | 1994-10-03 |
| AU3569193A (en) | 1993-10-07 |
| NO931009D0 (no) | 1993-03-19 |
| CN1077886A (zh) | 1993-11-03 |
| DE4210939A1 (de) | 1993-10-07 |
| MX9301667A (es) | 1993-11-01 |
| KR930021208A (ko) | 1993-11-22 |
| CA2093106A1 (en) | 1993-10-03 |
| PL298321A1 (en) | 1993-10-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU7734391A (en) | Essential fatty acid treatment | |
| AU3265695A (en) | Novel naphthyridine derivative and medicinal composition thereof | |
| IL112029A (en) | Raloxifine and related compounds for use as medicaments for the treatment of disorders associated with an excess of tachykinin | |
| IL107978A0 (en) | Mannitol derivatives processes for the preparation thereof and pharmaceutical compositions containing the same | |
| AU659456B2 (en) | Fatty acid treatment | |
| ZA932348B (en) | New 9-fluoro-7-oxo-7H-pyrido/1,2,3-de/1,4/benzoxazine-6-carboxylic acids and esters | |
| EP0577023A3 (en) | Angiotensin-ii receptor-antagonists for the treatment of arrhythmices | |
| AU3569293A (en) | 7-oxo-7H-pyrido(1,2,3-de)(1,4)benzoxazine-6-carboxylic acids and esters | |
| AU2806692A (en) | Medicament for the treatment of anxiety | |
| IL105229A0 (en) | The use of 7-oxo-7h-pyrido(1,2,3-de)(1,4)benzoxazine-6-carboxylic acids and esters as medicaments | |
| GB9103278D0 (en) | Drug for the treatment of dermatitis | |
| ZA936311B (en) | Combretastatin derivatives with antitumoral activity and process for the preparation thereof | |
| AU4096789A (en) | The use of lactam derivatives in the treatment of cognitive disorders | |
| AU1485197A (en) | Diamines in the treatment of arrhythmia | |
| PL313116A1 (en) | Application of n-alkalated 1,4-dihydropridinocarboxylic esters as drugs | |
| IL104756A0 (en) | Composition for the treatment of glaucoma | |
| EP0562231A3 (en) | Esters, process for their preparation and use | |
| EP0467537A3 (en) | Novel benzothiazepine esters, their preparation and formulations for therapeutic use | |
| GB2254555B (en) | The use of 4, 9, 11-trienic steroid esters in aquaculture | |
| EP0591765A3 (en) | 1,4-dihydropyridine-alkoxy and alkylamino esters as antihypertensives | |
| AU627874B2 (en) | Amino-benzenesulfonamides in the treatment of glaucoma | |
| IL93184A0 (en) | Pharmaceutical compositions containing fatty acids and methods for the use thereof | |
| IL96293A0 (en) | Pharmaceutical compositions containing fatty acids and methods for the use thereof | |
| IL106813A0 (en) | Combretastatin derivatives with antitumoral activity and process for the preparation thereof | |
| IL122731A0 (en) | Pharmaceutical compositions for the treatment of arrhythmia |